W. Alexander Mann

1.1k total citations
31 papers, 783 citations indexed

About

W. Alexander Mann is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, W. Alexander Mann has authored 31 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 13 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Molecular Biology. Recurrent topics in W. Alexander Mann's work include Lipoproteins and Cardiovascular Health (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Lipid metabolism and disorders (5 papers). W. Alexander Mann is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Lipid metabolism and disorders (5 papers). W. Alexander Mann collaborates with scholars based in Germany, United States and United Kingdom. W. Alexander Mann's co-authors include Ulrike Beisiegel†, H. Bryan Brewer, Nicolette Meyer, J M Hoeg, Loren A. Zech, D. Gareth Evans, Heiner Greten, Richard E. Gregg, Franz Rinninger and William J. Cain and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Kidney International.

In The Last Decade

W. Alexander Mann

31 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Alexander Mann Germany 17 421 342 262 171 171 31 783
W.J. McConathy United States 13 359 0.9× 352 1.0× 275 1.0× 128 0.7× 236 1.4× 21 838
E. de Wit Netherlands 16 297 0.7× 240 0.7× 347 1.3× 146 0.9× 164 1.0× 26 771
Junichiro Tohyama United States 14 381 0.9× 245 0.7× 240 0.9× 118 0.7× 166 1.0× 17 790
S I Skarlatos United States 12 326 0.8× 165 0.5× 207 0.8× 186 1.1× 103 0.6× 18 671
Isabel Beucler France 16 260 0.6× 284 0.8× 278 1.1× 163 1.0× 82 0.5× 39 869
Maartje E. Visser Netherlands 12 488 1.2× 397 1.2× 247 0.9× 356 2.1× 207 1.2× 13 939
Shozo Kobori Japan 15 332 0.8× 175 0.5× 266 1.0× 106 0.6× 143 0.8× 36 863
Debi K. Swertfeger United States 16 253 0.6× 212 0.6× 306 1.2× 99 0.6× 168 1.0× 23 773
Sumeet A. Khetarpal United States 15 292 0.7× 292 0.9× 214 0.8× 254 1.5× 143 0.8× 24 784
E M Rubin United States 6 556 1.3× 325 1.0× 370 1.4× 102 0.6× 203 1.2× 6 943

Countries citing papers authored by W. Alexander Mann

Since Specialization
Citations

This map shows the geographic impact of W. Alexander Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Alexander Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Alexander Mann more than expected).

Fields of papers citing papers by W. Alexander Mann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Alexander Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Alexander Mann. The network helps show where W. Alexander Mann may publish in the future.

Co-authorship network of co-authors of W. Alexander Mann

This figure shows the co-authorship network connecting the top 25 collaborators of W. Alexander Mann. A scholar is included among the top collaborators of W. Alexander Mann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Alexander Mann. W. Alexander Mann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zukunft, Sven, et al.. (2020). Human platelets are a source of collagen I. Haematologica. 106(3). 899–902. 3 indexed citations
2.
Mann, Ulrike, et al.. (2018). Fake news? Biotin interference in thyroid immunoassays. Clinica Chimica Acta. 484. 320–322. 15 indexed citations
3.
Knappe, Ulrich J., C. A. J. J. Jaspers, Ali Al-Omari, et al.. (2016). Ectopic Adrenocorticotropic Hormone–Secreting Pituitary Adenomas: An Underestimated Entity. Neurosurgery. 80(4). 525–533. 13 indexed citations
4.
Mann, W. Alexander, Déborah Morris-Rosendahl, Mato Nagel, et al.. (2015). Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis. Kidney International. 88(5). 1070–1078. 39 indexed citations
5.
Elgheznawy, Amro, Rüdiger Popp, Paul Rogowski, et al.. (2015). Metformin reduces hyper-reactivity of platelets from patients with polycystic ovary syndrome by improving mitochondrial integrity. Thrombosis and Haemostasis. 114(9). 569–578. 26 indexed citations
6.
Evans, D. Gareth, et al.. (2011). Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the Apolipoprotein A5 gene. European journal of medical research. 16(2). 79–79. 8 indexed citations
7.
Mann, W. Alexander. (2010). Treatment for prolactinomas and hyperprolactinaemia: a lifetime approach. European Journal of Clinical Investigation. 41(3). 334–342. 18 indexed citations
8.
Knappe, Ulrich J., et al.. (2009). Ultrasound-assisted Microsurgery for Cushing's Disease. Experimental and Clinical Endocrinology & Diabetes. 119(4). 191–200. 21 indexed citations
9.
Evans, D. Gareth, Jens Aberle, Dorte Wendt, et al.. (2001). A polymorphism, L162V, in the peroxisome proliferator-activated receptor α (PPAR α) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus. Journal of Molecular Medicine. 79(4). 198–204. 58 indexed citations
10.
Evans, D. Gareth, W. Alexander Mann, Jocelyn de Heer, et al.. (2000). Variation in the gene for human peroxisome proliferator activated receptor γ (PPARγ) does not play a major role in the development of morbid obesity. International Journal of Obesity. 24(5). 647–651. 37 indexed citations
11.
12.
Evans, D. Gareth, et al.. (1998). Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia. Journal of Molecular Medicine. 76(5). 355–364. 21 indexed citations
13.
14.
Feussner, Giso, et al.. (1996). Apolipoprotein E2 (Arg‐136→Cys), a variant of apolipoprotein E associated with late‐onset dominance of type III hyperlipoproteinaemia. European Journal of Clinical Investigation. 26(1). 13–23. 24 indexed citations
15.
Rader, Daniel J., W. Alexander Mann, William J. Cain, et al.. (1995). The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.. Journal of Clinical Investigation. 95(3). 1403–1408. 169 indexed citations
16.
Mann, W. Alexander, P Lohse, Richard E. Gregg, et al.. (1995). Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu).. Journal of Clinical Investigation. 96(2). 1100–1107. 26 indexed citations
17.
Mann, W. Alexander, et al.. (1995). Trials of the effects of drugs and hormones on lipids and lipoproteins. Current Opinion in Lipidology. 6(6). 354–359. 2 indexed citations
18.
Mann, W. Alexander, Nicolette Meyer, W. Weber, et al.. (1995). Apolipoprotein E and lipoprotein lipase co‐ordinately enhance binding and uptake of chylomicrons by human hepatocytes. European Journal of Clinical Investigation. 25(11). 880–882. 25 indexed citations
19.
Rader, Daniel J., W. Alexander Mann, H.G. Kraft, et al.. (1994). The LDL receptor is not required for normal catabolism of Lp(a) in humans. Atherosclerosis. 109(1-2). 284–285. 1 indexed citations
20.
Mann, W. Alexander, Richard E. Gregg, Dennis L. Sprecher, & H. Bryan Brewer. (1989). Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1005(3). 239–244. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W.J. McConathy Breakdown of academic impact, for papers by E. de Wit Breakdown of academic impact, for papers by Junichiro Tohyama Breakdown of academic impact, for papers by S I Skarlatos Breakdown of academic impact, for papers by Isabel Beucler Breakdown of academic impact, for papers by Maartje E. Visser Breakdown of academic impact, for papers by Shozo Kobori Breakdown of academic impact, for papers by Debi K. Swertfeger Breakdown of academic impact, for papers by Sumeet A. Khetarpal Breakdown of academic impact, for papers by E M Rubin
Rankless by CCL
2026